Naming of medicines

The MHRA considers each application for a product name to ensure that the proposed name will allow the medicine to be taken safely and correctly.

The name must also comply with legislative requirements and the MHRA has issued naming policy guidance with respect to umbrella segments of product names. This section also helps explain the change of names of some medicines which previously could exist with two different names which was done in order to reduce the risk of errors.


Page last modified: 07 September 2005